跳至主要内容
临床试验/NL-OMON55458
NL-OMON55458招募中不适用

Intraprocedural assessment of Ablation Margins using COMPuted tomography co-registration in primary LivEr Tumor treatment with percutanEous ablation: IAMCOMPLETE primary - IAMCOMPLETE primary

eids Universitair Medisch Centrum0 个研究点目标入组 23 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
23

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Age 18 yrs or above
  • 2. HCC very early (0) or early stage (A) according to the BCLC staging system
  • Either de novo or recurrent HCC (prior locoregional therapy is allowed in the
  • 3. Candidate for percutaneous thermal ablation as discussed in a
  • multidisciplinary tumor board. Ablation as *bridge-to-transplant* is allowed in

排除标准

  • 1. Estimated GFR <30 ml/min
  • 2. Morbid obesitas or any pulmonary condition that is a contraindication to
  • prolonged apnea and high jet-ventilation
  • 3. Child Pugh C liver status
  • 4. Portal vein tumor invasion
  • 5. Extrahepatic metastasis
  • 6. Uncorrectable coagulopathy
  • 7. Any psychological, familial, sociological or geographical condition
  • potentially hampering compliance with the study protocol and follow-up schedule
  • 8. Inability or unwillingness to give informed consent

研究者

相似试验

Intraprocedural assessment of Ablation Margins using... | 临床试验